BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $324,727 | +8.2% | 8,400 | +5.6% | 0.01% | -8.3% |
| Q3 2023 | $300,220 | -14.6% | 7,955 | +3.1% | 0.01% | -20.0% |
| Q2 2023 | $351,516 | +8.0% | 7,715 | -3.8% | 0.02% | 0.0% |
| Q1 2023 | $325,405 | -17.7% | 8,023 | +3.4% | 0.02% | -25.0% |
| Q4 2022 | $395,603 | -6.0% | 7,761 | -0.8% | 0.02% | -16.7% |
| Q3 2022 | $421,000 | -14.6% | 7,820 | +1.8% | 0.02% | -22.6% |
| Q2 2022 | $493,000 | -17.1% | 7,679 | +0.0% | 0.03% | +14.8% |
| Q1 2022 | $595,000 | -9.6% | 7,677 | +0.1% | 0.03% | -18.2% |
| Q4 2021 | $658,000 | +6.5% | 7,666 | -0.2% | 0.03% | -31.2% |
| Q3 2021 | $618,000 | +0.2% | 7,684 | +0.3% | 0.05% | -4.0% |
| Q2 2021 | $617,000 | -4.5% | 7,659 | +0.0% | 0.05% | -21.9% |
| Q1 2021 | $646,000 | +5.2% | 7,658 | +0.0% | 0.06% | -12.3% |
| Q4 2020 | $614,000 | -0.3% | 7,656 | +0.0% | 0.07% | -18.9% |
| Q3 2020 | $616,000 | -6.5% | 7,655 | +0.0% | 0.09% | -12.6% |
| Q2 2020 | $659,000 | +6.1% | 7,654 | +0.0% | 0.10% | -1.0% |
| Q1 2020 | $621,000 | -3.0% | 7,653 | +0.0% | 0.10% | -4.6% |
| Q4 2019 | $640,000 | -4.3% | 7,652 | +0.0% | 0.11% | -9.9% |
| Q3 2019 | $669,000 | +7.0% | 7,651 | +0.3% | 0.12% | +8.0% |
| Q2 2019 | $625,000 | +1.0% | 7,631 | +0.2% | 0.11% | -4.3% |
| Q1 2019 | $619,000 | +8.0% | 7,613 | -12.5% | 0.12% | +0.9% |
| Q4 2018 | $573,000 | -1.9% | 8,705 | +15.0% | 0.12% | -9.4% |
| Q3 2018 | $584,000 | +19.9% | 7,572 | -2.4% | 0.13% | +2.4% |
| Q3 2017 | $487,000 | +3.8% | 7,759 | +0.3% | 0.12% | -1.6% |
| Q2 2017 | $469,000 | +21.2% | 7,739 | +3.8% | 0.13% | +13.4% |
| Q1 2017 | $387,000 | +17.3% | 7,459 | +0.3% | 0.11% | +13.1% |
| Q4 2016 | $330,000 | -6.5% | 7,437 | +0.3% | 0.10% | -12.4% |
| Q3 2016 | $353,000 | +5.7% | 7,417 | +0.3% | 0.11% | -1.7% |
| Q2 2016 | $334,000 | +8.8% | 7,395 | +0.3% | 0.12% | +4.5% |
| Q1 2016 | $307,000 | +8.1% | 7,375 | -0.8% | 0.11% | -10.6% |
| Q4 2015 | $284,000 | +17.8% | 7,438 | +1.2% | 0.12% | +8.8% |
| Q3 2015 | $241,000 | -60.2% | 7,351 | -15.0% | 0.11% | -62.2% |
| Q2 2015 | $605,000 | – | 8,646 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |